Quantcast

Latest dengue Stories

2014-07-21 23:02:00

New research report “OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020” prepared by GlobalData is now available at MarketPublishers.com. According to the study, the live-attenuated vaccines are forecast to dominate the dengue vaccine market through to 2020. London, UK (PRWEB) July 21, 2014 Deemed to be responsible for over 100 million infections each year, the dengue virus (DENV) is the world’s most prevalent arthropod-borne virus. The live-attenuated...

2014-07-17 16:23:47

ReportsnReports.com adds "OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020" to its store. This report provides an overview of top line dengue vaccine market revenue from 2015-2020 across five major markets (5MM: Brazil, India, Mexico, Singapore and Thailand). DALLAS, July 17, 2014 /PRNewswire-iReach/ -- Among the five major pharmaceutical markets (5MM: Brazil, India, Mexico, Singapore and Thailand), Brazil and Mexico are projected to be the leading...

2014-06-24 23:05:15

The Bill & Melinda Gates Foundation and the Carlos Slim Health Institute partner to fund UCSF-based FIRST (Fighting Infections through Research, Science and Technology) program; a $6 million collaboration to fight neglected tropical diseases in Mesoamerica San Francisco, CA (PRWEB) June 24, 2014 SSI, a San Francisco nonprofit founded by Eva Harris, UC Berkeley Professor of Infectious Disease and Vaccinology and former MacArthur "Genius" award winner, has worked to minimize...

2014-04-10 16:23:57

CAMPINAS, Brazil, April 10, 2014 /PRNewswire/ -- The National Technical Commission for Biosecurity (CTNBio), the collegiate body responsible for approval and regulation of transgenic organisms in Brazil, today approved the commercial release of the genetically modified (GM) mosquito, OX513A, developed by Oxitec. It is the first GM insect to be considered safe for commercial use in Brazil and the latest of a long series of biotechnology approvals by CTNBio. The Oxitec...

2014-03-13 12:29:00

Pharmaceutical companies work with governments in the region to increase disease awareness and access to treatment BUENOS AIRES, Argentina, March 13, 2014 /PRNewswire/ -- The high incidence of human immunodeficiency virus (HIV), Chagas, dengue and influenza H1N1, as well as the unavailability of adequate treatments for these infectious diseases, spell opportunities for pharmaceutical companies across Latin America to develop new, improved diagnosis and treatment methods. New analysis from...

2014-02-27 18:33:27

By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV. Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human...

2014-02-18 09:02:53

Discovery by North Carolina researchers described at biophysical society meeting may advance development of vaccines to fight global, mosquito-borne scourge Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever. Despite its heavy toll, the...

Study Explores Evolution Of Bacteria That Can Be Used To Fight Dengue
2013-12-16 12:43:03

Instituto Gulbenkian de Ciencia Wolbachia, a symbiont that resides naturally up to 70% of all insect species, are probably the most prevalent infectious bacteria on Earth. In 2008 Luis Teixeira, now a principal investigator at the Instituto Gulbenkian de Ciência (IGC, Portugal), and other scientists have discovered that Wolbachia can protect their hosts against viral infections. Since then, several studies have been made to further investigate the interactions between Wolbachia and...

2013-08-27 23:23:45

New Study Finds InBios' DENV Detect IgM ELISA Effective for Rapid Diagnosis of Acute Or Recent Dengue Virus Infection Seattle, WA (PRWEB) August 27, 2013 A new study conducted by researchers at the John A. Burns School of Medicine, University of Hawaii, evaluated the InBios DENV Detect IgM Capture ELISA for qualitative detection of IgM antibodies to dengue virus recombinant antigens (1). Well characterized clinical serum samples collected from Hawaii, Vietnam, Niue, Singapore and...

2013-08-13 11:16:11

A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR’s Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may become the world’s first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus. This research done in collaboration with Singapore’s Novartis Institute of Tropical Diseases (NITD) and Beijing Institute of...


Latest dengue Reference Libraries

69_91adf9a2d64d7fdcac1a7b084facc7ac
2011-01-12 16:33:15

Dengue fever and dengue hemorrhagic fever (DHF), caused by the dengue virus, is among the spectrum of acute febrile tropical disease and is transmitted by mosquitoes. Occurring mainly in the tropics it can be life threatening and is caused by four closely related virus stereotypes of the genus Flavivirus. It was identified and named in 1779. It has a nickname of "breakbone fever" due to it causing sever generalized bodyache. It tends to be more prevalent in the urban districts of its range...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'